Knockdown experiments confirmed that reducing YY1 expression restored miR-526b-3p levels and decreased E2F1 expression, leading to growth arrest and reduced tumorigenicity in CRC cells [63]. The gene discussed is E2F1; the disease is colorectal carcinoma.